Article
SARS-CoV-2 Omicron variant spike protein maintains the ability to bind and activate human platelets: Comparison with the wild-type.
Scientific reports - 9 Apr 2026
Kusudo Eriko, Kawamoto Shuji, Matsumoto Tsuguhiro, Egi Moritoki
Abstract excerpt
Ongoing mutations in the SARS-CoV-2 spike protein contribute to the persistence of COVID-19. While the wild-type (WT) spike protein enhances platelet activity, the effects of the Omicron variant remain unclear. This study compared the effects of WT and Omicron spike proteins on platelet function in 10 healthy participants. We evaluated spike protein binding, P-selectin (platelet activation marker) expression, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
